IL18 and Alzheimer disease: To determine if inflammasome signaling proteins may be used as biomarkers of MCI and AD, we determined the area under the curve (AUC) for the control vs. MCI, MCI vs. AD and control vs. AD (Table 1 and Table 2) for ASC and IL-18.